nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—Ifosfamide—testicular cancer	0.295	0.456	CbGbCtD
Arformoterol—CYP2C19—Ifosfamide—testicular cancer	0.122	0.189	CbGbCtD
Arformoterol—CYP2C9—Ifosfamide—testicular cancer	0.102	0.157	CbGbCtD
Arformoterol—CYP2C9—Cisplatin—testicular cancer	0.0494	0.0762	CbGbCtD
Arformoterol—CYP2D6—Vinblastine—testicular cancer	0.0493	0.076	CbGbCtD
Arformoterol—CYP2D6—Doxorubicin—testicular cancer	0.0303	0.0467	CbGbCtD
Arformoterol—Dehydration—Doxorubicin—testicular cancer	0.000441	0.00125	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Methotrexate—testicular cancer	0.00044	0.00125	CcSEcCtD
Arformoterol—Tachycardia—Etoposide—testicular cancer	0.000438	0.00124	CcSEcCtD
Arformoterol—Dyspnoea—Cisplatin—testicular cancer	0.000437	0.00124	CcSEcCtD
Arformoterol—Skin disorder—Etoposide—testicular cancer	0.000436	0.00124	CcSEcCtD
Arformoterol—Dry skin—Doxorubicin—testicular cancer	0.000434	0.00123	CcSEcCtD
Arformoterol—Hypokalaemia—Doxorubicin—testicular cancer	0.000431	0.00122	CcSEcCtD
Arformoterol—Angina pectoris—Epirubicin—testicular cancer	0.000431	0.00122	CcSEcCtD
Arformoterol—Bronchitis—Epirubicin—testicular cancer	0.000426	0.00121	CcSEcCtD
Arformoterol—Diarrhoea—Dactinomycin—testicular cancer	0.000425	0.00121	CcSEcCtD
Arformoterol—Nasopharyngitis—Doxorubicin—testicular cancer	0.000424	0.0012	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000423	0.0012	CcSEcCtD
Arformoterol—Vomiting—Bleomycin—testicular cancer	0.000423	0.0012	CcSEcCtD
Arformoterol—Hypotension—Etoposide—testicular cancer	0.00042	0.00119	CcSEcCtD
Arformoterol—Rash—Bleomycin—testicular cancer	0.000419	0.00119	CcSEcCtD
Arformoterol—Gastritis—Doxorubicin—testicular cancer	0.000419	0.00119	CcSEcCtD
Arformoterol—Pain—Cisplatin—testicular cancer	0.000419	0.00119	CcSEcCtD
Arformoterol—Dermatitis—Bleomycin—testicular cancer	0.000419	0.00119	CcSEcCtD
Arformoterol—Hypersensitivity—Ifosfamide—testicular cancer	0.000419	0.00119	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000411	0.00117	CcSEcCtD
Arformoterol—Conjunctivitis—Methotrexate—testicular cancer	0.00041	0.00116	CcSEcCtD
Arformoterol—Influenza—Doxorubicin—testicular cancer	0.00041	0.00116	CcSEcCtD
Arformoterol—Asthma—Doxorubicin—testicular cancer	0.00041	0.00116	CcSEcCtD
Arformoterol—Asthenia—Ifosfamide—testicular cancer	0.000408	0.00116	CcSEcCtD
Arformoterol—Feeling abnormal—Cisplatin—testicular cancer	0.000404	0.00115	CcSEcCtD
Arformoterol—Pruritus—Ifosfamide—testicular cancer	0.000402	0.00114	CcSEcCtD
Arformoterol—Haematuria—Methotrexate—testicular cancer	0.000402	0.00114	CcSEcCtD
Arformoterol—Dyspnoea—Etoposide—testicular cancer	0.0004	0.00114	CcSEcCtD
Arformoterol—Hyperglycaemia—Epirubicin—testicular cancer	0.000399	0.00113	CcSEcCtD
Arformoterol—Somnolence—Etoposide—testicular cancer	0.000399	0.00113	CcSEcCtD
Arformoterol—Angina pectoris—Doxorubicin—testicular cancer	0.000399	0.00113	CcSEcCtD
Arformoterol—Nausea—Bleomycin—testicular cancer	0.000395	0.00112	CcSEcCtD
Arformoterol—Vomiting—Dactinomycin—testicular cancer	0.000394	0.00112	CcSEcCtD
Arformoterol—Bronchitis—Doxorubicin—testicular cancer	0.000394	0.00112	CcSEcCtD
Arformoterol—Rash—Dactinomycin—testicular cancer	0.000391	0.00111	CcSEcCtD
Arformoterol—Diarrhoea—Ifosfamide—testicular cancer	0.000389	0.0011	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000388	0.0011	CcSEcCtD
Arformoterol—Body temperature increased—Cisplatin—testicular cancer	0.000387	0.0011	CcSEcCtD
Arformoterol—Fatigue—Etoposide—testicular cancer	0.000387	0.0011	CcSEcCtD
Arformoterol—Constipation—Etoposide—testicular cancer	0.000384	0.00109	CcSEcCtD
Arformoterol—Pain—Etoposide—testicular cancer	0.000384	0.00109	CcSEcCtD
Arformoterol—Conjunctivitis—Epirubicin—testicular cancer	0.000384	0.00109	CcSEcCtD
Arformoterol—Urinary tract infection—Epirubicin—testicular cancer	0.000384	0.00109	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000381	0.00108	CcSEcCtD
Arformoterol—Haematuria—Epirubicin—testicular cancer	0.000376	0.00107	CcSEcCtD
Arformoterol—Dizziness—Ifosfamide—testicular cancer	0.000376	0.00107	CcSEcCtD
Arformoterol—Pharyngitis—Methotrexate—testicular cancer	0.000376	0.00107	CcSEcCtD
Arformoterol—Urinary tract disorder—Methotrexate—testicular cancer	0.000374	0.00106	CcSEcCtD
Arformoterol—Urethral disorder—Methotrexate—testicular cancer	0.000371	0.00105	CcSEcCtD
Arformoterol—Sinusitis—Epirubicin—testicular cancer	0.00037	0.00105	CcSEcCtD
Arformoterol—Feeling abnormal—Etoposide—testicular cancer	0.00037	0.00105	CcSEcCtD
Arformoterol—Hyperglycaemia—Doxorubicin—testicular cancer	0.000369	0.00105	CcSEcCtD
Arformoterol—Nausea—Dactinomycin—testicular cancer	0.000369	0.00105	CcSEcCtD
Arformoterol—Gastrointestinal pain—Etoposide—testicular cancer	0.000367	0.00104	CcSEcCtD
Arformoterol—Visual impairment—Methotrexate—testicular cancer	0.000365	0.00104	CcSEcCtD
Arformoterol—Vomiting—Ifosfamide—testicular cancer	0.000362	0.00103	CcSEcCtD
Arformoterol—Hypersensitivity—Cisplatin—testicular cancer	0.000361	0.00103	CcSEcCtD
Arformoterol—Rash—Ifosfamide—testicular cancer	0.000358	0.00102	CcSEcCtD
Arformoterol—Dermatitis—Ifosfamide—testicular cancer	0.000358	0.00102	CcSEcCtD
Arformoterol—Urticaria—Etoposide—testicular cancer	0.000357	0.00101	CcSEcCtD
Arformoterol—Rhinitis—Epirubicin—testicular cancer	0.000355	0.00101	CcSEcCtD
Arformoterol—Abdominal pain—Etoposide—testicular cancer	0.000355	0.00101	CcSEcCtD
Arformoterol—Body temperature increased—Etoposide—testicular cancer	0.000355	0.00101	CcSEcCtD
Arformoterol—Conjunctivitis—Doxorubicin—testicular cancer	0.000355	0.00101	CcSEcCtD
Arformoterol—Urinary tract infection—Doxorubicin—testicular cancer	0.000355	0.00101	CcSEcCtD
Arformoterol—Asthenia—Cisplatin—testicular cancer	0.000352	0.000999	CcSEcCtD
Arformoterol—Pharyngitis—Epirubicin—testicular cancer	0.000352	0.000999	CcSEcCtD
Arformoterol—Cardiac disorder—Methotrexate—testicular cancer	0.000351	0.000998	CcSEcCtD
Arformoterol—Urinary tract disorder—Epirubicin—testicular cancer	0.00035	0.000994	CcSEcCtD
Arformoterol—Oedema peripheral—Epirubicin—testicular cancer	0.000349	0.000991	CcSEcCtD
Arformoterol—Haematuria—Doxorubicin—testicular cancer	0.000348	0.000989	CcSEcCtD
Arformoterol—Connective tissue disorder—Epirubicin—testicular cancer	0.000348	0.000989	CcSEcCtD
Arformoterol—Urethral disorder—Epirubicin—testicular cancer	0.000347	0.000986	CcSEcCtD
Arformoterol—Sinusitis—Doxorubicin—testicular cancer	0.000343	0.000973	CcSEcCtD
Arformoterol—Immune system disorder—Methotrexate—testicular cancer	0.000342	0.000971	CcSEcCtD
Arformoterol—Visual impairment—Epirubicin—testicular cancer	0.000341	0.00097	CcSEcCtD
Arformoterol—Mediastinal disorder—Methotrexate—testicular cancer	0.000341	0.000969	CcSEcCtD
Arformoterol—Nausea—Ifosfamide—testicular cancer	0.000338	0.000959	CcSEcCtD
Arformoterol—Diarrhoea—Cisplatin—testicular cancer	0.000335	0.000953	CcSEcCtD
Arformoterol—Mental disorder—Methotrexate—testicular cancer	0.000332	0.000942	CcSEcCtD
Arformoterol—Hypersensitivity—Etoposide—testicular cancer	0.000331	0.00094	CcSEcCtD
Arformoterol—Malnutrition—Methotrexate—testicular cancer	0.00033	0.000936	CcSEcCtD
Arformoterol—Cardiac disorder—Epirubicin—testicular cancer	0.000329	0.000934	CcSEcCtD
Arformoterol—Rhinitis—Doxorubicin—testicular cancer	0.000329	0.000933	CcSEcCtD
Arformoterol—Pharyngitis—Doxorubicin—testicular cancer	0.000325	0.000924	CcSEcCtD
Arformoterol—Urinary tract disorder—Doxorubicin—testicular cancer	0.000324	0.000919	CcSEcCtD
Arformoterol—Oedema peripheral—Doxorubicin—testicular cancer	0.000323	0.000917	CcSEcCtD
Arformoterol—Dysgeusia—Methotrexate—testicular cancer	0.000323	0.000917	CcSEcCtD
Arformoterol—Asthenia—Etoposide—testicular cancer	0.000322	0.000915	CcSEcCtD
Arformoterol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000322	0.000915	CcSEcCtD
Arformoterol—Urethral disorder—Doxorubicin—testicular cancer	0.000321	0.000913	CcSEcCtD
Arformoterol—Immune system disorder—Epirubicin—testicular cancer	0.00032	0.000909	CcSEcCtD
Arformoterol—Mediastinal disorder—Epirubicin—testicular cancer	0.000319	0.000907	CcSEcCtD
Arformoterol—Back pain—Methotrexate—testicular cancer	0.000319	0.000905	CcSEcCtD
Arformoterol—Pruritus—Etoposide—testicular cancer	0.000318	0.000902	CcSEcCtD
Arformoterol—Arrhythmia—Epirubicin—testicular cancer	0.000317	0.000899	CcSEcCtD
Arformoterol—Visual impairment—Doxorubicin—testicular cancer	0.000316	0.000897	CcSEcCtD
Arformoterol—Vomiting—Cisplatin—testicular cancer	0.000312	0.000885	CcSEcCtD
Arformoterol—Mental disorder—Epirubicin—testicular cancer	0.00031	0.000882	CcSEcCtD
Arformoterol—Rash—Cisplatin—testicular cancer	0.000309	0.000878	CcSEcCtD
Arformoterol—Dermatitis—Cisplatin—testicular cancer	0.000309	0.000877	CcSEcCtD
Arformoterol—Malnutrition—Epirubicin—testicular cancer	0.000308	0.000876	CcSEcCtD
Arformoterol—Diarrhoea—Etoposide—testicular cancer	0.000307	0.000873	CcSEcCtD
Arformoterol—Ill-defined disorder—Methotrexate—testicular cancer	0.000306	0.000868	CcSEcCtD
Arformoterol—Cardiac disorder—Doxorubicin—testicular cancer	0.000304	0.000864	CcSEcCtD
Arformoterol—Tension—Epirubicin—testicular cancer	0.000303	0.00086	CcSEcCtD
Arformoterol—Dysgeusia—Epirubicin—testicular cancer	0.000302	0.000858	CcSEcCtD
Arformoterol—Nervousness—Epirubicin—testicular cancer	0.0003	0.000851	CcSEcCtD
Arformoterol—Back pain—Epirubicin—testicular cancer	0.000298	0.000847	CcSEcCtD
Arformoterol—Malaise—Methotrexate—testicular cancer	0.000297	0.000844	CcSEcCtD
Arformoterol—Dizziness—Etoposide—testicular cancer	0.000297	0.000843	CcSEcCtD
Arformoterol—Muscle spasms—Epirubicin—testicular cancer	0.000297	0.000842	CcSEcCtD
Arformoterol—Immune system disorder—Doxorubicin—testicular cancer	0.000296	0.000841	CcSEcCtD
Arformoterol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000295	0.000839	CcSEcCtD
Arformoterol—Arrhythmia—Doxorubicin—testicular cancer	0.000293	0.000832	CcSEcCtD
Arformoterol—Nausea—Cisplatin—testicular cancer	0.000291	0.000827	CcSEcCtD
Arformoterol—Cough—Methotrexate—testicular cancer	0.000288	0.000817	CcSEcCtD
Arformoterol—Mental disorder—Doxorubicin—testicular cancer	0.000287	0.000816	CcSEcCtD
Arformoterol—Ill-defined disorder—Epirubicin—testicular cancer	0.000286	0.000813	CcSEcCtD
Arformoterol—Vomiting—Etoposide—testicular cancer	0.000286	0.000811	CcSEcCtD
Arformoterol—Malnutrition—Doxorubicin—testicular cancer	0.000285	0.000811	CcSEcCtD
Arformoterol—Agitation—Epirubicin—testicular cancer	0.000283	0.000805	CcSEcCtD
Arformoterol—Rash—Etoposide—testicular cancer	0.000283	0.000804	CcSEcCtD
Arformoterol—Dermatitis—Etoposide—testicular cancer	0.000283	0.000803	CcSEcCtD
Arformoterol—Headache—Etoposide—testicular cancer	0.000281	0.000799	CcSEcCtD
Arformoterol—Arthralgia—Methotrexate—testicular cancer	0.000281	0.000797	CcSEcCtD
Arformoterol—Chest pain—Methotrexate—testicular cancer	0.000281	0.000797	CcSEcCtD
Arformoterol—Myalgia—Methotrexate—testicular cancer	0.000281	0.000797	CcSEcCtD
Arformoterol—Tension—Doxorubicin—testicular cancer	0.00028	0.000795	CcSEcCtD
Arformoterol—Dysgeusia—Doxorubicin—testicular cancer	0.000279	0.000794	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000279	0.000791	CcSEcCtD
Arformoterol—Malaise—Epirubicin—testicular cancer	0.000278	0.00079	CcSEcCtD
Arformoterol—Discomfort—Methotrexate—testicular cancer	0.000277	0.000787	CcSEcCtD
Arformoterol—Nervousness—Doxorubicin—testicular cancer	0.000277	0.000787	CcSEcCtD
Arformoterol—Back pain—Doxorubicin—testicular cancer	0.000276	0.000784	CcSEcCtD
Arformoterol—Muscle spasms—Doxorubicin—testicular cancer	0.000274	0.000779	CcSEcCtD
Arformoterol—Palpitations—Epirubicin—testicular cancer	0.000273	0.000774	CcSEcCtD
Arformoterol—Cough—Epirubicin—testicular cancer	0.000269	0.000764	CcSEcCtD
Arformoterol—Anaphylactic shock—Methotrexate—testicular cancer	0.000269	0.000764	CcSEcCtD
Arformoterol—Infection—Methotrexate—testicular cancer	0.000267	0.000759	CcSEcCtD
Arformoterol—Nausea—Etoposide—testicular cancer	0.000267	0.000758	CcSEcCtD
Arformoterol—Hypertension—Epirubicin—testicular cancer	0.000266	0.000756	CcSEcCtD
Arformoterol—Ill-defined disorder—Doxorubicin—testicular cancer	0.000265	0.000752	CcSEcCtD
Arformoterol—Nervous system disorder—Methotrexate—testicular cancer	0.000264	0.000749	CcSEcCtD
Arformoterol—Chest pain—Epirubicin—testicular cancer	0.000263	0.000746	CcSEcCtD
Arformoterol—Arthralgia—Epirubicin—testicular cancer	0.000263	0.000746	CcSEcCtD
Arformoterol—Myalgia—Epirubicin—testicular cancer	0.000263	0.000746	CcSEcCtD
Arformoterol—Agitation—Doxorubicin—testicular cancer	0.000262	0.000745	CcSEcCtD
Arformoterol—Anxiety—Epirubicin—testicular cancer	0.000262	0.000743	CcSEcCtD
Arformoterol—Skin disorder—Methotrexate—testicular cancer	0.000261	0.000742	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000261	0.000741	CcSEcCtD
Arformoterol—Discomfort—Epirubicin—testicular cancer	0.000259	0.000737	CcSEcCtD
Arformoterol—Malaise—Doxorubicin—testicular cancer	0.000257	0.000731	CcSEcCtD
Arformoterol—Dry mouth—Epirubicin—testicular cancer	0.000257	0.000729	CcSEcCtD
Arformoterol—Palpitations—Doxorubicin—testicular cancer	0.000252	0.000716	CcSEcCtD
Arformoterol—Anaphylactic shock—Epirubicin—testicular cancer	0.000252	0.000715	CcSEcCtD
Arformoterol—Oedema—Epirubicin—testicular cancer	0.000252	0.000715	CcSEcCtD
Arformoterol—Hypotension—Methotrexate—testicular cancer	0.000251	0.000714	CcSEcCtD
Arformoterol—Infection—Epirubicin—testicular cancer	0.00025	0.00071	CcSEcCtD
Arformoterol—Cough—Doxorubicin—testicular cancer	0.000249	0.000707	CcSEcCtD
Arformoterol—Nervous system disorder—Epirubicin—testicular cancer	0.000247	0.000701	CcSEcCtD
Arformoterol—Hypertension—Doxorubicin—testicular cancer	0.000246	0.0007	CcSEcCtD
Arformoterol—Tachycardia—Epirubicin—testicular cancer	0.000246	0.000698	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000245	0.000696	CcSEcCtD
Arformoterol—Skin disorder—Epirubicin—testicular cancer	0.000245	0.000694	CcSEcCtD
Arformoterol—Insomnia—Methotrexate—testicular cancer	0.000243	0.000691	CcSEcCtD
Arformoterol—Chest pain—Doxorubicin—testicular cancer	0.000243	0.00069	CcSEcCtD
Arformoterol—Arthralgia—Doxorubicin—testicular cancer	0.000243	0.00069	CcSEcCtD
Arformoterol—Myalgia—Doxorubicin—testicular cancer	0.000243	0.00069	CcSEcCtD
Arformoterol—Anxiety—Doxorubicin—testicular cancer	0.000242	0.000688	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000241	0.000685	CcSEcCtD
Arformoterol—Discomfort—Doxorubicin—testicular cancer	0.00024	0.000682	CcSEcCtD
Arformoterol—Dyspnoea—Methotrexate—testicular cancer	0.00024	0.000681	CcSEcCtD
Arformoterol—Somnolence—Methotrexate—testicular cancer	0.000239	0.000679	CcSEcCtD
Arformoterol—Dry mouth—Doxorubicin—testicular cancer	0.000238	0.000675	CcSEcCtD
Arformoterol—Dyspepsia—Methotrexate—testicular cancer	0.000237	0.000672	CcSEcCtD
Arformoterol—Hypotension—Epirubicin—testicular cancer	0.000235	0.000668	CcSEcCtD
Arformoterol—Anaphylactic shock—Doxorubicin—testicular cancer	0.000233	0.000661	CcSEcCtD
Arformoterol—Oedema—Doxorubicin—testicular cancer	0.000233	0.000661	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000232	0.00066	CcSEcCtD
Arformoterol—Fatigue—Methotrexate—testicular cancer	0.000232	0.000659	CcSEcCtD
Arformoterol—Infection—Doxorubicin—testicular cancer	0.000231	0.000657	CcSEcCtD
Arformoterol—Pain—Methotrexate—testicular cancer	0.00023	0.000653	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000229	0.000651	CcSEcCtD
Arformoterol—Nervous system disorder—Doxorubicin—testicular cancer	0.000228	0.000649	CcSEcCtD
Arformoterol—Insomnia—Epirubicin—testicular cancer	0.000228	0.000647	CcSEcCtD
Arformoterol—Tachycardia—Doxorubicin—testicular cancer	0.000227	0.000646	CcSEcCtD
Arformoterol—Skin disorder—Doxorubicin—testicular cancer	0.000226	0.000643	CcSEcCtD
Arformoterol—Dyspnoea—Epirubicin—testicular cancer	0.000224	0.000637	CcSEcCtD
Arformoterol—Somnolence—Epirubicin—testicular cancer	0.000224	0.000636	CcSEcCtD
Arformoterol—Feeling abnormal—Methotrexate—testicular cancer	0.000222	0.00063	CcSEcCtD
Arformoterol—Dyspepsia—Epirubicin—testicular cancer	0.000222	0.000629	CcSEcCtD
Arformoterol—Gastrointestinal pain—Methotrexate—testicular cancer	0.00022	0.000625	CcSEcCtD
Arformoterol—Hypotension—Doxorubicin—testicular cancer	0.000218	0.000618	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000217	0.000617	CcSEcCtD
Arformoterol—Fatigue—Epirubicin—testicular cancer	0.000217	0.000616	CcSEcCtD
Arformoterol—Pain—Epirubicin—testicular cancer	0.000215	0.000611	CcSEcCtD
Arformoterol—Constipation—Epirubicin—testicular cancer	0.000215	0.000611	CcSEcCtD
Arformoterol—Urticaria—Methotrexate—testicular cancer	0.000214	0.000607	CcSEcCtD
Arformoterol—Abdominal pain—Methotrexate—testicular cancer	0.000213	0.000604	CcSEcCtD
Arformoterol—Body temperature increased—Methotrexate—testicular cancer	0.000213	0.000604	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000212	0.000603	CcSEcCtD
Arformoterol—Insomnia—Doxorubicin—testicular cancer	0.000211	0.000598	CcSEcCtD
Arformoterol—Dyspnoea—Doxorubicin—testicular cancer	0.000208	0.00059	CcSEcCtD
Arformoterol—Feeling abnormal—Epirubicin—testicular cancer	0.000207	0.000589	CcSEcCtD
Arformoterol—Somnolence—Doxorubicin—testicular cancer	0.000207	0.000588	CcSEcCtD
Arformoterol—Gastrointestinal pain—Epirubicin—testicular cancer	0.000206	0.000585	CcSEcCtD
Arformoterol—Dyspepsia—Doxorubicin—testicular cancer	0.000205	0.000582	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000201	0.000571	CcSEcCtD
Arformoterol—Fatigue—Doxorubicin—testicular cancer	0.000201	0.00057	CcSEcCtD
Arformoterol—Urticaria—Epirubicin—testicular cancer	0.0002	0.000568	CcSEcCtD
Arformoterol—Pain—Doxorubicin—testicular cancer	0.000199	0.000566	CcSEcCtD
Arformoterol—Constipation—Doxorubicin—testicular cancer	0.000199	0.000566	CcSEcCtD
Arformoterol—Abdominal pain—Epirubicin—testicular cancer	0.000199	0.000565	CcSEcCtD
Arformoterol—Body temperature increased—Epirubicin—testicular cancer	0.000199	0.000565	CcSEcCtD
Arformoterol—Hypersensitivity—Methotrexate—testicular cancer	0.000198	0.000563	CcSEcCtD
Arformoterol—Asthenia—Methotrexate—testicular cancer	0.000193	0.000548	CcSEcCtD
Arformoterol—Feeling abnormal—Doxorubicin—testicular cancer	0.000192	0.000545	CcSEcCtD
Arformoterol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00019	0.000541	CcSEcCtD
Arformoterol—Pruritus—Methotrexate—testicular cancer	0.00019	0.00054	CcSEcCtD
Arformoterol—Hypersensitivity—Epirubicin—testicular cancer	0.000185	0.000527	CcSEcCtD
Arformoterol—Urticaria—Doxorubicin—testicular cancer	0.000185	0.000525	CcSEcCtD
Arformoterol—Abdominal pain—Doxorubicin—testicular cancer	0.000184	0.000523	CcSEcCtD
Arformoterol—Body temperature increased—Doxorubicin—testicular cancer	0.000184	0.000523	CcSEcCtD
Arformoterol—Diarrhoea—Methotrexate—testicular cancer	0.000184	0.000523	CcSEcCtD
Arformoterol—Asthenia—Epirubicin—testicular cancer	0.000181	0.000513	CcSEcCtD
Arformoterol—Pruritus—Epirubicin—testicular cancer	0.000178	0.000506	CcSEcCtD
Arformoterol—Dizziness—Methotrexate—testicular cancer	0.000178	0.000505	CcSEcCtD
Arformoterol—Diarrhoea—Epirubicin—testicular cancer	0.000172	0.000489	CcSEcCtD
Arformoterol—Hypersensitivity—Doxorubicin—testicular cancer	0.000172	0.000487	CcSEcCtD
Arformoterol—Vomiting—Methotrexate—testicular cancer	0.000171	0.000486	CcSEcCtD
Arformoterol—Rash—Methotrexate—testicular cancer	0.00017	0.000482	CcSEcCtD
Arformoterol—Dermatitis—Methotrexate—testicular cancer	0.000169	0.000481	CcSEcCtD
Arformoterol—Headache—Methotrexate—testicular cancer	0.000169	0.000479	CcSEcCtD
Arformoterol—Asthenia—Doxorubicin—testicular cancer	0.000167	0.000475	CcSEcCtD
Arformoterol—Dizziness—Epirubicin—testicular cancer	0.000166	0.000473	CcSEcCtD
Arformoterol—Pruritus—Doxorubicin—testicular cancer	0.000165	0.000468	CcSEcCtD
Arformoterol—Vomiting—Epirubicin—testicular cancer	0.00016	0.000455	CcSEcCtD
Arformoterol—Nausea—Methotrexate—testicular cancer	0.00016	0.000454	CcSEcCtD
Arformoterol—Diarrhoea—Doxorubicin—testicular cancer	0.000159	0.000453	CcSEcCtD
Arformoterol—Rash—Epirubicin—testicular cancer	0.000159	0.000451	CcSEcCtD
Arformoterol—Dermatitis—Epirubicin—testicular cancer	0.000159	0.00045	CcSEcCtD
Arformoterol—Headache—Epirubicin—testicular cancer	0.000158	0.000448	CcSEcCtD
Arformoterol—Dizziness—Doxorubicin—testicular cancer	0.000154	0.000437	CcSEcCtD
Arformoterol—Nausea—Epirubicin—testicular cancer	0.00015	0.000425	CcSEcCtD
Arformoterol—Vomiting—Doxorubicin—testicular cancer	0.000148	0.000421	CcSEcCtD
Arformoterol—Rash—Doxorubicin—testicular cancer	0.000147	0.000417	CcSEcCtD
Arformoterol—Dermatitis—Doxorubicin—testicular cancer	0.000147	0.000417	CcSEcCtD
Arformoterol—Headache—Doxorubicin—testicular cancer	0.000146	0.000414	CcSEcCtD
Arformoterol—Nausea—Doxorubicin—testicular cancer	0.000138	0.000393	CcSEcCtD
